| Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the … AC Kalil, ML Metersky, M Klompas, J Muscedere, DA Sweeney, ... Clinical infectious diseases 63 (5), e61-e111, 2016 | 3818 | 2016 |
| Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of … JP Metlay, GW Waterer, AC Long, A Anzueto, J Brozek, K Crothers, ... American journal of respiratory and critical care medicine 200 (7), e45-e67, 2019 | 3291 | 2019 |
| Cyclophosphamide versus placebo in scleroderma lung disease DP Tashkin, R Elashoff, PJ Clements, J Goldin, MD Roth, DE Furst, ... New England Journal of Medicine 354 (25), 2655-2666, 2006 | 1981 | 2006 |
| Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease DP Tashkin, R Elashoff, PJ Clements, MD Roth, DE Furst, RM Silver, ... American journal of respiratory and critical care medicine 176 (10), 1026-1034, 2007 | 591 | 2007 |
| Hospital‐acquired pressure ulcers: results from the national Medicare patient safety monitoring system study CH Lyder, Y Wang, M Metersky, M Curry, R Kliman, NR Verzier, DR Hunt Journal of the American Geriatrics Society 60 (9), 1603-1608, 2012 | 443 | 2012 |
| Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry TR Aksamit, AE O’Donnell, A Barker, KN Olivier, KL Winthrop, ... Chest 151 (5), 982-992, 2017 | 401 | 2017 |
| Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of … AC Kalil, ML Metersky, M Klompas, J Muscedere, DA Sweeney, ... Clinical Infectious Diseases 63 (5), 575-582, 2016 | 341 | 2016 |
| National trends in patient safety for four common conditions, 2005–2011 Y Wang, N Eldridge, ML Metersky, NR Verzier, TP Meehan, MM Pandolfi, ... New England Journal of Medicine 370 (4), 341-351, 2014 | 336 | 2014 |
| Predicting bacteremia in patients with community-acquired pneumonia ML Metersky, A Ma, DW Bratzler, PM Houck American journal of respiratory and critical care medicine 169 (3), 342-347, 2004 | 315 | 2004 |
| Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza ML Metersky, RG Masterton, H Lode, TM File Jr, T Babinchak International Journal of Infectious Diseases 16 (5), e321-e331, 2012 | 300 | 2012 |
| Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis JD Chalmers, CS Haworth, ML Metersky, MR Loebinger, F Blasi, O Sibila, ... New England Journal of Medicine 383 (22), 2127-2137, 2020 | 255 | 2020 |
| Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones ML Metersky, A Ma, PM Houck, DW Bratzler Chest 131 (2), 466-473, 2007 | 221 | 2007 |
| Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia EM Mortensen, EA Halm, MJ Pugh, LA Copeland, M Metersky, MJ Fine, ... Jama 311 (21), 2199-2208, 2014 | 202 | 2014 |
| Development, validation, and results of a measure of 30‐day readmission following hospitalization for pneumonia PK Lindenauer, SLT Normand, EE Drye, Z Lin, K Goodrich, MM Desai, ... Journal of Hospital Medicine 6 (3), 142-150, 2011 | 189 | 2011 |
| Trend in ventilator-associated pneumonia rates between 2005 and 2013 ML Metersky, Y Wang, M Klompas, S Eckenrode, A Bakullari, N Eldridge Jama 316 (22), 2427-2429, 2016 | 165 | 2016 |
| Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies JA Ramirez, DM Musher, SE Evans, CD Cruz, KA Crothers, CA Hage, ... Chest 158 (5), 1896-1911, 2020 | 157 | 2020 |
| AIDS-related spontaneous pneumothorax: risk factors and treatment ML Metersky, HG Colt, LK Olson, TG Shanks Chest 108 (4), 946-951, 1995 | 135 | 1995 |
| An administrative claims model for profiling hospital 30-day mortality rates for pneumonia patients DW Bratzler, SLT Normand, Y Wang, WJ O'Donnell, M Metersky, LF Han, ... PloS one 6 (4), e17401, 2011 | 131 | 2011 |
| Regenerative metaplastic clones in COPD lung drive inflammation and fibrosis W Rao, S Wang, M Duleba, S Niroula, K Goller, J Xie, R Mahalingam, ... Cell 181 (4), 848-864. e18, 2020 | 130 | 2020 |
| Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia D Chen, MI Restrepo, MJ Fine, MJ V. Pugh, A Anzueto, ML Metersky, ... American journal of respiratory and critical care medicine 184 (3), 312-316, 2011 | 126 | 2011 |
